Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan
· Delayed Price · Currency is TWD 44.75
+2.85 (6.80%)
Aug 15, 2025, 1:30 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 5.78 billion as of August 15, 2025. Its market cap has decreased by -32.26% in one year.
Market Cap
5.78B
Enterprise Value
4.59B
Revenue
173.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
44.75
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has increased from 4.86B to 5.78B, an increase of 18.91%. That is a compound annual growth rate of 5.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 5.78B | -15.41% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 224.90B |
| PharmaEssentia | 167.97B |
| Bora Pharmaceuticals Co., LTD. | 97.17B |
| Lotus Pharmaceutical | 52.73B |
| Oneness Biotech | 34.00B |
| Lumosa Therapeutics | 28.78B |
| Polaris Group | 27.23B |
| Center Laboratories | 26.78B |